NVO: 诺和诺德公司

NVO新闻

• 17:35 Roche's 9M 2026 Sales Rise on Strong Drug Demand, Pipeline Advances
• 17:00 As the Market's Party Shrinks, Here's One Stock to Buy
• 15:31 NVO vs. VKTX: Which Obesity Stock Could Deliver Bigger Gains?
• 13:45 Regeneron: Is The Market Undervaluing Its Growth Potential (NASDAQ:REGN)
• 13:20 How Will Novo's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?
• 12:30 Obesity ETFs to Gain as Novo's CagriSema Shows 25% Weight Loss
• 11:47 Novo's New Obesity Drug Just Hit 25% Weight Loss in Women
• 05:24 Omeros: The Trade After European Rejection (NASDAQ:OMER)
• 18:33 Eli Lilly Stock (LLY) Hits All-Time High Ahead of Earnings - TipRanks.com
• 15:34 Prothena's Partnership Strategy: Growth Driver or Limitation?
• 12:15 Can Viking Therapeutics Carve Out a Place in the Obesity Market?
• 09:29 Oracle Joins Forces With AstraZeneca to Put AI to Work in Drug Research
• 20:45 Novo Nordisk (NVO) Stock Sinks As Market Gains: Here's Why
• 18:23 Eli Lilly, IBD Stock Of The Day, Rides Foundayo, Medicare Bridge To Buy Point
• 13:15 How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?
• 12:00 Is Trending Stock Novo Nordisk A/S (NVO) a Buy Now?
• 15:52 Viking Therapeutics Starts Phase III Development of Obesity Pill
• 19:52 QUICK SPARK: This New ETF Goes Beyond Eli Lilly, Novo Nordisk and Targets the Peptide Boom
• 19:52 快速爆点：这只新ETF超越礼来、诺和诺德，瞄准肽类热潮
• 16:38 Roche Expands Obesity Pipeline With Rona's RNAi Candidate
• 10:51 The Zacks Analyst Blog Highlights Walmart, Visa, Novo Nordisk, Village Super Market and Empire Petroleum
• 20:45 Why Novo Nordisk (NVO) Dipped More Than Broader Market Today
• 19:38 Top Analyst Reports for Walmart, Visa & Novo Nordisk
• 12:00 Why A Biotech M&A Wave May Hit This Winter